From:
bco-bounces@lists.oulu.fi [mailto:bco-bounces@lists.oulu.fi] On Behalf Of anita.tienhaara@helsinki.fi
Sent: 2. marraskuuta 2009 10:41
To: FinBioNet
Subject: [Bco] Nordic EMBL Partnership is seeking outstanding
international candidates for the positions of PhD Students in Molecular
Medicine
Nordic EMBL Partnership for Molecular Medicine
The
Nordic EMBL Partnership for Molecular Medicine was established in 2007 as a
joint venture between the European Molecular Biology Laboratory (EMBL) and the
Universities of Helsinki, Finland, Oslo, Norway and Umeå, Sweden and involves
building of national sister institutions in the three countries. The
partnership between EMBL, the Institute for Molecular Medicine Finland (FIMM),
the Centre for Molecular Medicine Norway (NCMM) and the Laboratory for
Molecular Infection Medicine Sweden (MIMS) is dedicated to the growing field of
life sciences that investigates the molecular basis of disease and explores
molecularly and genetically based treatments. Aiming to combine complementary
strengths in the Nordic EMBL Partnership each partner brings in a unique set of
expertise, skills and facilities encompassing EMBL’s recognized research
strengths in the areas of molecular, cellular and developmental biology,
bioinformatics and structural biology complemented by Norway’s expertise in
molecular mechanisms of disease, Sweden’s focus on microbial pathogenicity and
molecular infection medicine and Finland’s strength in human genomics and
medical systems biology which equip the partners to tackle some of the most
challenging problems of biomedicine. The Partnership provides access to
scientific infrastructure, including databases, facilities and instrumentation,
as well as to clinical materials and networks and training activities provided
by the partners and adopts the EMBL model for international recruitment, staff
turnover and scientific reviews.
The
Nordic EMBL Partnership is now seeking outstanding international candidates for
the positions of PhD Students in Molecular
Medicine.
FIMM: Helsinki, Finland
> Molecular Medicine
MIMS: Umeå, Sweden
> Molecular Infection Medicine
NCMM: Oslo, Norway
> Molecular Medicine – Disease Mechanisms
For
further details and more comprehensive job descriptions please visit the
websites of FIMM (www.fimm.fi), NCMM (www.ncmm.uio.no) and MIMS (www.mims.se) .
Applications for all positions should be sent electronically following the
instructions given by the institutes’ websites.
The
submission deadline is 15 December 2009 .
-------------------------------------------
This
message was sent to you by FinBioNet
Anita
Tienhaara
Institute
of Biotechnology
P.O.
Box 56
FIN-00014
University of Helsinki, finland
tel.
+358 9 191 59656
fax
+358 9 191 59550
anita.tienhaara@helsinki.fi